OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis
Zhulin Wu, Li He, Lina Yang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 11

Showing 11 citing articles:

Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease
Jingxia Du, H.-A. Shui, Rongjun Chen, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8031-8052
Open Access | Times Cited: 5

Sialylation: A Cloak for Tumors to Trick the Immune System in the Microenvironment
Xiaoman Zhou, Kaijun Chi, Chairui Zhang, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 832-832
Open Access | Times Cited: 13

Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases
Kévin Toussaint, Aline Appert-Collin, Hamid Morjani, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4868-4868
Open Access | Times Cited: 16

Oseltamivir enhances 5-FU sensitivity in esophageal squamous carcinoma with high SPNS1
Xin Yang, Jiao Ye, Yingying Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116367-116367
Open Access | Times Cited: 2

Genetics of enzymatic dysfunctions in metabolic disorders and cancer
Mélanie Mahé, Tiffany J. Rios-Fuller, Andrea Karolin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6

The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma
Siyi Li, Zhulin Wu, Qiuyue Li, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 8

Identification of drug responsible glycogene signature in liver carcinoma from meta-analysis using RNA-seq data
Tatsuya Koreeda, Hiroshi Honda
Glycoconjugate Journal (2024) Vol. 41, Iss. 2, pp. 133-149
Closed Access

Unveiling the Impact of Endogenous Sialidases on Human Non-Infectious Disease Pathogenesis
R. Surkova, Anastasia V. Poznyak, Dmitry Kashirskikh, et al.
OnLine Journal of Biological Sciences (2024) Vol. 24, Iss. 3, pp. 302-312
Open Access

A study on construction of a prognosis model for liver cancer based on analgesic targets and screening therapeutic drugs
Xueyan Jiang, Yaodong Ping, Yuan Chen, et al.
Genes & Genomics (2024) Vol. 46, Iss. 7, pp. 831-850
Closed Access

GM1 gangliosidosis, Morquio disease, galactosialidosis, and sialidosis
J. T. GALLAGHER, N. Yingling, Susana Esteves, et al.
Elsevier eBooks (2024), pp. 645-664
Closed Access

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
Yongqi Ding, Yiyang Gong, Hong Zeng, et al.
Aging (2023) Vol. 15, Iss. 7, pp. 2631-2666
Open Access

Page 1

Scroll to top